Unknown

Dataset Information

Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta-analysis.


ABSTRACT: Defibrillation threshold (DFT) testing has been an integral part of implantable cardioverter-defibrillator (ICD) implantation to confirm appropriate sensing of ventricular fibrillation and to establish an adequate safety margin for defibrillation. However, there is a lack of evidence regarding benefits of routine DFT testing. Therefore, we performed a meta-analysis to assess its mortality benefit. We searched MEDLINE for studies comparing mortality outcomes in ICD recipients who underwent DFT testing to those who did not. For the second analysis, studies comparing outcomes in patients with high- vs low-energy DFT were included. Odds ratio and standard errors were calculated, and inverse variance method in a random-effect model was used to combine effect sizes. Fifteen studies with 10,975 s

SUBMITTER: Kannabhiran M 

PROVIDER: S-EPMC6288554 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature